These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2311763)

  • 1. ADP-ribosylated elongation factor 2 (ADP-ribosyl-EF-2) is unable to promote translocation within the ribosome.
    Davydova EK; Ovchinnikov LP
    FEBS Lett; 1990 Feb; 261(2):350-2. PubMed ID: 2311763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced ribosomal binding of eukaryotic elongation factor 2 following ADP-ribosylation. Difference in binding selectivity between polyribosomes and reconstituted monoribosomes.
    Nygård O; Nilsson L
    Biochim Biophys Acta; 1985 Feb; 824(2):152-62. PubMed ID: 3970930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of elongation factor 2 (EF-2) inactivation upon phosphorylation. Phosphorylated EF-2 is unable to catalyze translocation.
    Ryazanov AG; Davydova EK
    FEBS Lett; 1989 Jul; 251(1-2):187-90. PubMed ID: 2753158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of elongation factor 2 and of adenosine diphosphate-ribosylated elongation factor 2 on translocation.
    Montanaro L; Sperti S; Testoni G; Mattioli A
    Biochem J; 1976 Apr; 156(1):15-23. PubMed ID: 182140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleotide binding to elongation factor 2 inactivated by diphtheria toxin.
    Burns G; Abraham AK; Vedeler A
    FEBS Lett; 1986 Nov; 208(2):217-20. PubMed ID: 3780964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-N6-Etheno-ADP-ribosylation of elongation factor-2 by diphtheria toxin.
    Giovane A; Balestrieri C; Quagliuolo L; Servillo L
    FEBS Lett; 1985 Oct; 191(2):191-4. PubMed ID: 2996930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic determination of the effects of ADP-ribosylation on the interaction of eukaryotic elongation factor 2 with ribosomes.
    Nygård O; Nilsson L
    J Biol Chem; 1990 Apr; 265(11):6030-4. PubMed ID: 2318846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfer RNA binding to 80S ribosomes from yeast: evidence for three sites.
    Triana F; Nierhaus KH; Chakraburtty K
    Biochem Mol Biol Int; 1994 Aug; 33(5):909-15. PubMed ID: 7987260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ADP-ribosylation and phosphorylation on the interaction of elongation factor 2 with guanylic nucleotides.
    Marzouki A; Sontag B; Lavergne JP; Vidonne C; Reboud JP; Reboud AM
    Biochimie; 1991; 73(7-8):1151-6. PubMed ID: 1742357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the endogenous ADP-ribosylation of wild-type and mutant elongation factor 2 in eukaryotic cells.
    Fendrick JL; Iglewski WJ; Moehring JM; Moehring TJ
    Eur J Biochem; 1992 Apr; 205(1):25-31. PubMed ID: 1313365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Truncated elongation factor G lacking the G domain promotes translocation of the 3' end but not of the anticodon domain of peptidyl-tRNA.
    Borowski C; Rodnina MV; Wintermeyer W
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4202-6. PubMed ID: 8633041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of adenosine diphosphate-ribosylated elongation factor 2 with ribosomes.
    Bermek E
    J Biol Chem; 1976 Nov; 251(21):6544-9. PubMed ID: 789367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the puromycin reaction. The ribosomal exclusion principle for AcPhe-tRNA binding re-examined.
    Geigenmüller U; Hausner TP; Nierhaus KH
    Eur J Biochem; 1986 Dec; 161(3):715-21. PubMed ID: 3024981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the binding of ADP-ribosylated human translocation factor to ribosomes.
    Bermek E
    Hamatol Bluttransfus; 1974; 14():308-13. PubMed ID: 4448421
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulation of elongation factor G GTPase activity by the ribosomal state. The effects of initiation factors and differentially bound tRNA, aminoacyl-tRNA, and peptidyl-tRNA.
    Voigt J; Nagel K
    J Biol Chem; 1993 Jan; 268(1):100-6. PubMed ID: 8416917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the nature of cellular ADP-ribosyltransferase from rat liver specific for elongation factor 2.
    Sayhan O; Ozdemirli M; Nurten R; Bermek E
    Biochem Biophys Res Commun; 1986 Sep; 139(3):1210-4. PubMed ID: 3094526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of non-ADP-ribosylatable, diphtheria toxin-resistant elongation factor 2 in Saccharomyces cerevisiae.
    Kimata Y; Harashima S; Kohno K
    Biochem Biophys Res Commun; 1993 Mar; 191(3):1145-51. PubMed ID: 8466491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Action of erythromycin and virginiamycin S on polypeptide synthesis in cell-free systems.
    Chinali G; Nyssen E; Di Giambattista M; Cocito C
    Biochim Biophys Acta; 1988 Nov; 951(1):42-52. PubMed ID: 3142522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of 2'-deoxynad for ADP-ribose transfer reactions.
    Wasson DB; Yamanaka H; Carson DA
    Adv Exp Med Biol; 1989; 253B():213-8. PubMed ID: 2514587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of the reactivity of three amino-acid residues in elongation factor 2 during its binding to ribosomes and translocation.
    Lavergne JP; Marzouki A; Reboud AM; Reboud JP
    Biochim Biophys Acta; 1990 Apr; 1048(2-3):231-7. PubMed ID: 2322578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.